Scienture (SCNX) Projected to Post Earnings on Tuesday

Scienture (NASDAQ:SCNXGet Free Report) is anticipated to announce its results before the market opens on Tuesday, March 24th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter.

Scienture Stock Down 3.1%

Shares of NASDAQ:SCNX opened at $0.45 on Tuesday. The business’s 50 day moving average is $0.46 and its 200 day moving average is $0.64. The stock has a market cap of $18.41 million, a P/E ratio of -0.45 and a beta of 3.00. Scienture has a 52-week low of $0.37 and a 52-week high of $3.17.

Institutional Trading of Scienture

A hedge fund recently bought a new stake in Scienture stock. Virtu Financial LLC acquired a new position in Scienture Holdings, Inc. (NASDAQ:SCNXFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.22% of Scienture as of its most recent SEC filing. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Analyst Upgrades and Downgrades

SCNX has been the subject of several research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Scienture in a report on Monday, December 29th. Wall Street Zen upgraded Scienture to a “hold” rating in a research note on Saturday. Finally, Maxim Group assumed coverage on shares of Scienture in a research note on Tuesday, February 24th. They issued a “buy” rating and a $1.50 price objective for the company. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Scienture presently has a consensus rating of “Hold” and an average target price of $1.50.

Check Out Our Latest Analysis on Scienture

Scienture Company Profile

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

See Also

Earnings History for Scienture (NASDAQ:SCNX)

Receive News & Ratings for Scienture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scienture and related companies with MarketBeat.com's FREE daily email newsletter.